StonvexLoading…
StonvexStonvexStonvexCore line items from CRVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $4.01M | $4.00M | $3.68M |
Operating Income | $-8.11M | $-28.29M | $-19.96M | $-11.92M |
Net Income | $-7.96M | $-26.97M | $-18.88M | $-11.15M |
EPS (Diluted) | $-0.86 | $-2.98 | $-2.10 | $-1.26 |
Total Assets | $15.11M | $22.88M | $30.61M | $38.08M |
Total Liabilities | $4.50M | $4.66M | $4.60M | $4.64M |
Cash & Equivalents | $7.94M | $8.24M | $9.44M | $8.32M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 9.26M | 9.25M | 9.25M | 9.25M |